Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Partially Randomized Patient Preference Trial to Assess the Quality of Life and Patency Rate After Minimally Invasive Cardiac Surgery-Coronary Artery Bypass Grafting: the MICS-CABG PRPP Trial

NCT05104320 is registered in ClinicalTrials.gov with Peking University Third Hospital as lead sponsor.

NCT NCT05104320
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05104320 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Partially Randomized Patient Preference Trial to Assess the Quality of Life and Patency Rate After Minimally Invasive Cardiac Surgery-Coronary Artery Bypass Grafting: the MICS-CABG PRPP Trial
Lead sponsor
Peking University Third Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
October 31, 2021
Completion date
December 31, 2024
Enrollment
248 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

minimally invasive cardiac surgery